Keyphrases
Biliary Malignancy
65%
Curative Resection
54%
CDC1
46%
Hilar Cholangiocarcinoma
43%
Donor Nephrectomy
43%
Robot-assisted Kidney Transplantation
43%
Resection
42%
Abdominal Organ Transplantation
34%
Dendritic Cells
30%
Transplant Surgery
29%
Recurrence-free Survival
29%
Tumor
29%
Handoff
27%
Performance Metrics
27%
Tumor Immunity
25%
Lymph Node Positive
24%
Positive Lymph Nodes
24%
Robotics
24%
Transcription Factor
24%
Robotic Training
23%
CDC2s
23%
Notch2
23%
Cytokine Signaling
21%
Staging Laparoscopy
21%
Teaching Robotics
21%
Early Colon Cancer
21%
Pediatric Patients
21%
HPB Fellowship
21%
Improved Survival
21%
Gastric Carcinoid
21%
WDFY4
21%
RelB
21%
Colon Cancer
21%
FMS-like Tyrosine Kinase 3 (FLT3)
21%
Parathyroid Carcinoma
21%
DC Development
21%
Myeloid Development
21%
Multi-institution
21%
Extrinsic Mechanism
21%
5-year Survival
21%
Appendiceal Neuroendocrine Tumor
21%
Cocaine Analog
21%
Parathyroid Cancer
21%
Adjuvant Therapy
21%
Small Intestinal Neuroendocrine Tumors
21%
Overall Survival
21%
Colon Resection
21%
Metric Model
21%
Surgery Fellowship
21%
Improved Outcomes
21%
Medicine and Dentistry
Surgery
100%
Cancer
70%
Transplantation
59%
Neuroendocrine Tumor
45%
Nephrectomy
43%
Living Donors
43%
Cholangiocarcinoma
43%
Neoplasm
40%
Transplant Surgery
31%
Lymph Node
26%
Overall Survival
24%
Parathyroid Carcinoma
21%
Colectomy
21%
Assisted Living
21%
Parathyroid Cancer
21%
Laparoscopic Surgery
21%
Pediatrics Patient
21%
Adjuvant Therapy
21%
Breast Cancer
21%
Colon Carcinoma
21%
Operating Room
21%
Carcinoid
21%
Kidney Graft
21%
Diseases
19%
Hypercalcaemia
16%
Recurrence Free Survival
15%
Recurrent Disease
15%
Bleeding
13%
Symptomatic Treatment
10%
Lung
10%
Pediatrics
10%
Appendectomy
10%
Colon Cancer Stage
10%
Clinical Stage
7%
Metastatic Carcinoma
6%
Haploinsufficiency
5%
Hyperparathyroidism
5%
Case Presentation
5%
Da Vinci Surgical System
5%
Parathyroid
5%
Parathyroid Hormone
5%
Germ Cell
5%
Parathyroid Adenoma
5%
Diagnosis
5%
Proportional Hazards Model
5%
Immunology and Microbiology
Dendritic Cell
67%
T-Helper Cell
27%
Cross-Presentation
24%
Cytokine Signaling
21%
Enhancer Region
21%
Tumor Antigen
21%
Tumor Immunity
21%
Cytotoxic T-Cell
21%
Germinal Center
21%
Transcription Factor RelB
21%
Cell Maturation
21%
Myeloid
21%
Immune Response
21%
DNA Immunization
21%
Neoantigen
21%
Immunology
19%
Humoral Immunity
16%
Dendritic Cell Subset
16%
Tumor Rejection
13%
CD4
13%
Cytokine
10%
B Cell
10%
Lymphotoxin
10%
Radiation Chimera
10%
Transcription Factors
9%
Lineages
9%
T Cell Activation
7%
Histocompatibility
7%
T Cell
7%
Listeria monocytogenes
5%
Follicular B Helper T Cells
5%
Macrophage Colony-Stimulating Factor
5%
Infectious Agent
5%
TNF Receptor Family
5%
Myelopoiesis
5%
Wild Type
5%